drugset / Trial / NCT04275193

The Safety and Efficacy of Zishenqing in Subjects With Active Systemic Lupus Erythematosus

NCT04275193 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study evaluates the safety and efficacy of the traditional chinese medicine Zishenqing in the treatment of active systemic lupus erythematosus.

Timeline

Start
2019-10-22
Primary completion
2022-03-01
Completion
2022-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Zishenqing Traditional medicine (herbal / TCM) 1 unknown Oral